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ABSTRACT 
Bipolar disorders are illnesses with recurring episodes of elevated or depressed mood. 
Although most affected individuals have periods when they are free of symptoms, they carry 
a life-long risk of relapse. The cause of the illness has not yet been established. During the 
last three decades, a growing number of brain imaging studies have shown differences in 
brain morphology between persons with a bipolar disorder and healthy controls, though the 
affected brain regions have varied greatly across studies. Too small sample sizes are likely 
one explanation of this variability. The aims of this thesis were to investigate i) differences in 
brain morphology between bipolar patients and healthy controls, ii) differences between 
subgroups of bipolar disorder, and iii) changes in brain morphology associated with illness 
progression. To these ends, we collected a large sample of bipolar disorder patients and 
examined their brains using magnetic resonance imaging. We then made analyses on group 
level. 
In Study 1, we analyzed differences in gray matter volume between persons with bipolar 
disorder and healthy controls. We found lower volume in the bilateral insula and medial 
prefrontal cortex in the bipolar group. We also found that these two regions covary in size. 
In Study 2, we examined if cortical volume, thickness, and surface area differ between 
patients with bipolar disorder I and II. We found that bipolar I subjects had thinner rostral 
temporal cortex than bipolar II subjects.  
Many patients with bipolar disorder experience psychotic symptoms during an illness 
episode. In Study 3, we investigated if gray matter volume differs between patients with a 
history of psychosis and those without. We found lower volume in the fusiform gyrus, 
dorsolateral prefrontal cortex, and inferior frontal cortex in the group of patients with 
previous psychosis. 
In Study 4, we analyzed if gray matter volume was associated with the lifetime number of 
manic or depressive episodes, or the duration of the illness in a group of patients with bipolar 
I disorder without comorbidity. We found a linear negative correlation between the volume of 
the dorsolateral prefrontal cortex and the lifetime number of manic episodes. This cross 
sectional analysis could, however, not establish if the volume reduction predates the manic 
episodes or is an effect of manic episodes. Therefore, we re-scanned the patients after six 
years. In study 5, we then compared those patients who had had at least one manic episode 
between baseline and follow-up with those who did not. We found that the volume in the 
dorsolateral and inferior frontal cortex decreased in the group who had had a manic episode. 
In summary, the studies suggest that bipolar disorder is associated with reduced gray matter 
volume in brain areas responsible for emotional regulation. We also found that the brain 
morphology differs between subgroups of bipolar disorder. Finally, our results suggest that 
manic episodes cause gray matter volume reduction in regions coupled to cognitive functions 
that tend to be impaired in bipolar disorder. 
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1 INTRODUCTION 
This thesis rests on the underlying assumption that bipolar disorder is a brain disease and that 
humans with bipolar disorder demonstrate specific alterations in brain morphology that can 
be captured with modern brain imaging techniques. Specifically, we aimed to test the 
hypotheses that bipolar disorder is associated with differences in volume in certain regions of 
the brain, that brain morphology differs between subtypes of bipolar disorder, and that 
progression of the illness leads to changes in brain morphology. To these ends, more than two 
hundred persons with bipolar disorder and more than one hundred healthy persons have been 
brain scanned using magnetic resonance tomography. 
Bipolar disorder is an illness of recurring episodes of abnormal states of mood. Its clinical 
presentation consists of pathologically elevated or severely depressed mood. During these 
mood episodes, the affected person’s behavior is notably changed and dysfunctional. A 
habitually calm and timid person can become talkative, extravagant, flirty, and loud during 
mania. Conversely, a joyful and energetic person can become introvert, apathetic, and 
suicidal during depression. Bipolar disorder carries a life-long risk of relapse, even if the 
acute phases are successfully treated. The disease burden in terms of mental and psychical 
health, premature death, social and economic factors is staggering on group level. Bipolar 
disorder entails high societal costs, due to long periods of inpatient care and lost productivity 
(M. Ekman, Granstrom, Omerov, Jacob, & Landen, 2013; Peele, Xu, & Kupfer, 2003). 
Needless to say, the illness also causes great concern for relatives and friends. Moreover, the 
suicide rates in bipolar disorder have been estimated to 7.8% in men and 4.9% in women 
(Nordentoft, Mortensen, & Pedersen, 2011). 
The causes of the illness remain unknown despite considerable research efforts in the last 
decades. New technology has enabled genetic studies, neurochemical analyses, as well as 
structural and functional examinations of the brains of living humans. But clinical studies of 
bipolar disorder are complicated by several factors. First, the course of the illness, with 
completely opposite symptoms during mania and depression, makes it difficult to separate 
state from trait. Second, cross-sectional studies of euthymic patients cannot separate causal 
factors from effects of the disease. For example, cognitive impairment has been found in 
persons with bipolar disorder when compared with healthy controls, but it has been difficult 
to establish whether this is a premorbid trait or a consequence of the disease. 
The clinical presentation of bipolar disorder is heterogeneous. The cardinal behavioural 
symptom during a manic episode can be euphoria and expansive behaviour, but also severe 
irritability. Many – but not all - patients experience psychotic symptoms during an episode. 
Some patients are completely recovered between mood episodes whereas others suffer from 
lingering mood symptoms or cognitive deficits. The dominant polarity of the recurring 
episodes also varies. Some patients have more depressive episodes and other more manic 
episodes. One reason for this diversity is due to the definition of the illness: The criteria for a 
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bipolar I diagnosis, in the contemporary diagnostic manuals, implicate that one manic episode 
is sufficient for a bipolar disorder diagnosis. 
The first study of brain structure in bipolar disorder was published in 1981. It was an analysis 
of ventricular volume, derived from computerized tomography (CT) scans. The study showed 
larger ventricular volumes in the bipolar sample (Pearlson & Veroff, 1981). Modern brain 
imaging studies, which usually have employed magnetic resonance tomography, have 
revealed wide-spread alterations in brain matter associated with bipolar disorder. But the 
findings have varied significantly across studies. This has probably been due to small sample 
sizes that precluded correction for medication and comorbid conditions. Different methods 
for processing and analyzing the images have also affected the results. Meta-analyses have 
attempted to reconcile these inconsistencies, but are hampered by publication bias. One meta-
analysis based on raw data rather than positive results demonstrated reduced gray matter 
volume in the right insula in patients with bipolar disorder (Selvaraj et al., 2012). Most brain 
imaging investigations of bipolar disorder have been cross-sectional studies of euthymic 
patients. The findings can therefore be interpreted either as brain structures that render the 
brain susceptible to develop mania or depression, or brain alterations caused by the illness.  
The aim of this thesis was to disentangle some of the inconsistencies regarding brain 
morphology in bipolar disorder that previous research has shown. In order to do that, efforts 
were made to collect a large group of persons with bipolar disorder and to perform a thorough 
phenotyping of each participant.  
This first chapter of the thesis will give an overview of bipolar disorder, neuropathology, 
methods for analyzing magnetic resonance images, and the cortical brain regions that are 
discussed in this thesis. 
 
1.1 BIPOLAR DISORDER 
 
1.1.1 History and conceptualization 
People with recurrent mania and depression have been described in medical literature from 
ancient Greece and Persia. The words melancholia and mania can be found in Greek medical 
literature from 2500 years ago. Six hundred years later, the Turkish physician Aretaeus of 
Cappadocia described episodes of mania and melancholia in the same person. He also 
distinguished melancholia in young persons from dementia, and mania from delirium. In the 
16th century, it was suggested that mental illnesses were disorders of the brain and that the 
two states of melancholia and mania could be symptoms of one illness. In 1735, the Dutch 
botanical expert Hermann Boerhaave wrote: “If melancholy increases so far, that from the 
great motion of liquid in the brain, the patient be thrown into a wild fury, it is called madness 
[mania] which differs only in degree from the sorrowful kind of melancholy, is its offspring, 
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produced from the same causes” (Boerhaave, 1735). The bipolar illness was thoroughly 
described by the German psychiatrist Emil Kraepelin in 1921, in his book Manic-depressive 
insanity and paranoia. He described a heterogeneous group of patients with the common 
symptoms of gradually alternating mood-states, fluctuating between mania and melancholia 
with different frequencies and sometimes persisting and/or mixed symptoms. He 
hypothesized that, despite the diversity among symptoms, they were presentations of a single 
morbid process. This view of the illness has persisted over the years and is the fundament of 
today’s syndromal diagnosis Bipolar Disorder. The current definitions of bipolar disorder that 
is used in clinical practice and scientific research are described in the two major diagnostic 
manuals the Diagnostic and Statistical Manual of Mental Disorders (DSM) and the 
International Statistical Classification of Diseases and Related Health Problems (ICD). The 
ICD-10 defines bipolar disorder as: 
“A disorder characterized by two or more episodes in which the patient's mood and activity 
levels are significantly disturbed, this disturbance consisting on some occasions of an 
elevation of mood and increased energy and activity (hypomania or mania) and on others of a 
lowering of mood and decreased energy and activity (depression). Repeated episodes of 
hypomania or mania only are classified as bipolar.” 
Some symptoms of bipolar disorder are shared with other psychiatric syndromes. First-
episode bipolar depression is very difficult to separate form a first depressive episode in a 
unipolar depressive illness. A manic episode with psychotic symptoms can be very hard to 
separate from other acute psychotic episodes in for example a paranoid schizophrenia. It is 
the course of the illness that is unique for the bipolar syndromes. Typically, the first episode 
of the illness occurs in the late teens - early twenties. Unlike schizophrenia, the first episode 
is not preceded by a prodromal phase of impaired function, and typically the first episode is 
followed by full remission. 
 
1.1.2 Epidemiology 
The prevalence of bipolar disorder is about 2% of the population. A recent review has 
estimated the lifetime prevalence of bipolar disorder type I to 1.06% and type II to 1.57% 
(Clemente et al., 2015). Nationality, ethnicity, and socio-economy all have limited impact on 
prevalence figures. Family history of bipolar disorder is a major risk factor. Whereas the 
lifetime risk for the disorder is 0.5-1.5% in the general population, first degree relatives of a 
person with bipolar disorder have a risk of 5-10%. The concordance rate in monozygotic 
twins is 40-70% (Craddock & Jones, 1999). The illness also carries an increased risk for other 
psychiatric illnesses. Comorbid anxiety disorders, ADHD, substance misuse, and borderline 
personality disorder are common. It has been estimated that 67% of bipolar I patients and 
76% of bipolar II have a comorbid psychiatric condition (McElroy et al., 2001). 
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1.1.3 Mania and Hypomania 
The manic episode is the core clinical presentation of bipolar disorder that is unique for the 
illness and separates it from recurring depressive illness. During a manic episode, the mood is 
elevated, expansive, and/or irritable. Energy is increased, the self-esteem is inflated. The 
patient with mania often presents as grandiose, talkative, and agitated. The racing of thoughts, 
loose associations, and rapid speech sometimes make the manic patient incomprehensible and 
unable to uphold a normal communication. A milder form of elevated mood is called 
hypomania. ICD-10 defines hypomania and mania as follows: 
“Hypomania: A disorder characterized by a persistent mild elevation of mood, increased 
energy and activity, and usually marked feelings of well-being and both physical and mental 
efficiency. Increased sociability, talkativeness, over-familiarity, increased sexual energy, and 
a decreased need for sleep are often present but not to the extent that they lead to severe 
disruption of work or result in social rejection. Irritability, conceit, and boorish behaviour 
may take the place of the more usual euphoric sociability. The disturbances of mood and 
behaviour are not accompanied by hallucinations or delusions.” 
“Mania: Mood is elevated out of keeping with the patient's circumstances and may vary from 
carefree joviality to almost uncontrollable excitement. Elation is accompanied by increased 
energy, resulting in overactivity, pressure of speech, and a decreased need for sleep. Attention 
cannot be sustained, and there is often marked distractibility. Self-esteem is often inflated 
with grandiose ideas and overconfidence. Loss of normal social inhibitions may result in 
behaviour that is reckless, foolhardy, or inappropriate to the circumstances, and out of 
character. 
DSM IV-criteria for a Manic episode 
A. A distinct period of abnormally and persistently elevated, expansive, or irritable 
mood, lasting at least 1 week (or any duration if hospitalization is necessary) 
 
B. During the period of mood disturbance, three (or more) of the following symptoms have 
persisted (4 if the mood is only irritable) and have been present to a significant degree:  
 
(1) increased self-esteem or grandiosity 
(2) decreased need for sleep (e.g., feels rested after only 3 hours of sleep) 
(3) more talkative than usual or pressure to keep talking 
(4) flight of ideas or subjective experience that thoughts are racing 
(5) distractibility (i.e., attention too easily drawn to unimportant or irrelevant external 
stimuli) 
(6) increase in goal-directed activity (either socially, at work or school, or sexually) or 
psychomotor agitation 
(7) excessive involvement in pleasurable activities that have a high potential for painful 
consequences (e.g., engaging in unrestrained buying sprees, sexual indiscretions, or foolish 
business investments)"  
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1.1.4 Depression 
Depression is a very common syndrome in the general population. Neither the diagnostic 
criteria in the DSM-IV or the ICD-10 separate bipolar depression from unipolar depression. 
Nevertheless, studies have suggested that some symptoms are more common in bipolar 
depression than unipolar depression: psychomotor retardation, early awakening and 
worsening of mood in the morning, difficulty to think, and psychosis (Cuellar, Johnson, & 
Winters, 2005; Forty et al., 2008; Mitchell & Malhi, 2004).  
DSM-IV Criteria for Major Depressive Disorder (MDD) 
• Depressed mood or a loss of interest or pleasure in daily activities for more than two 
weeks. 
• Mood represents a change from the person's baseline. 
• Impaired function: social, occupational, educational. 
• Specific symptoms, at least 5 of these 9, present nearly every day: 
1. Depressed mood or irritable most of the day, nearly every day, as indicated by either 
subjective report (e.g., feels sad or empty) or observation made by others (e.g., appears 
tearful). 
2. Markedly diminished interest or pleasure in all, or almost all, activities most of the day, 
nearly every day  
3. Significant weight loss when not dieting or weight gain (e.g., a change of more than 5% of 
body weight in a month), or decrease or increase in appetite nearly every day. 
4. Insomnia or hypersomnia 
5. Psychomotor agitation or retardation 
6. Fatigue or loss of energy 
7. Feelings of worthlessness or excessive or inappropriate guilt 
8. Diminished ability to think or concentrate, or more indecisiveness 
9. Suicidality: recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation 
without a specific plan, or a suicide attempt or a specific plan for committing suicide  
 
1.1.5 Subtypes of bipolar disorder 
In DSM-IV, Bipolar I disorder is characterized by one or more manic episode/s. Bipolar 
disorder type II requires one or more hypomanic episodes and one or more major depressive 
episodes. The ICD-10 criteria require two or more episodes also for Bipolar I. 
 
1.1.6 Euthymia 
Euthymia or euthymic mood define the state when a patient does not fulfill criteria for a 
depressive, manic, or hypomanic episode. Euthymia does not imply that the patient has 
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regained complete function. It may take months to recover after a mood episode. Several 
studies have for example shown cognitive deficits in the euthymic state (Bourne et al., 2013). 
The deficits are spread over different cognitive domains, e.g., executive function, verbal 
learning and memory, attention, and response inhibition.  
 
1.1.7 Psychosis 
The term psychosis was introduced into the medical literature by Ernst von Feuchtersleben in 
1845 (Beer, 1996) and has since been used for a variety of symptoms related to mental 
illness. It was initially used as a synonym to psychopathy, separating melancholia, mania, 
dementia, and idiocy from neuroses such as cramps, palsies, and neuralgia. In the 1920’s, 
Kraepelin defined the psychoses to only include dementia praecox and manic-depressive 
insanity (Beer, 1996). Throughout the twentieth century, the Kraepelinian dichotomy has 
been challenged by the identification of atypical psychoses and schizoaffective psychoses 
among others. Consequently the term psychosis has shifted from classifying syndromes to an 
umbrella term for a group of symptoms.  
In the two diagnostic manuals, DSM-IV-TR and ICD-10, psychosis is used as a label for 
symptoms of perceptive, cognitive, and psychomotor dysfunction including hallucinations, 
delusions, disorganized speech, and disorganized or catatonic behaviour (American 
Psychiatric Association, 2000; World Health Organisation, 1992). Still, the definition of 
psychosis varies across different diagnoses even within the DSM-IV-TR. Whereas 
hallucinations and delusions are considered psychotic in mood disorders, only those 
hallucinations that are not accompanied by insight are defined as psychotic in substance use 
disorders or in psychosis due to a general medical condition.  
In ICD-10, the severity of psychotic symptoms must be taken into account. Diagnosing a 
depressive episode with psychotic symptoms requires “the presence of hallucinations, 
delusions, psychomotor retardation, or stupor so severe that ordinary social activities are 
impossible” (World Health Organisation, 1992). Psychotic symptoms during a manic episode 
are diagnosed when “delusions or hallucinations are present, or the excitement, excessive 
motor activity, and flight of ideas are so extreme that the subject is incomprehensible or 
inaccessible to ordinary communication” (World Health Organisation, 1992).  
In schizophrenia, psychosis is a sine qua non that defines the illness. However, lifetime 
prevalence of psychosis is also common in other illnesses such as bipolar disorder, substance 
use disorders, and temporal lobe epilepsy. Moreover, in surveys of the general population 10-
25% of responders report having experienced at least one isolated psychotic symptom (Preti, 
Bonventre, Ledda, Petretto, & Masala, 2007) even though only a small fraction of these 
subjects fulfil criteria for a mental illness (Kendler, Gallagher, Abelson, & Kessler, 1996). In 
bipolar disorder, psychotic symptoms has been reported to occur in up to 68% of patients 
with a manic episode (Canuso, Bossie, Zhu, Youssef, & Dunner, 2008), in 11% of patients 
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with a bipolar depression, and in 25% of patients with a mixed state (Perugi, Akiskal, 
Micheli, Toni, & Madaro, 2001). 
 
1.2 FUNCTIONAL NEUROANATOMY 
 
1.2.1 Atlases 
To describe a certain region in the brain, researchers must refer to the some atlas or other 
framework. There are several different atlases available. One of the oldest and possibly most 
well-known is the Brodmann definitions of the cerebral cortex. In 1909, Korbinian 
Brodmann, a German neurologist, divided the brain surface into 52 different areas based both 
on gross anatomical features such as gyrii and sulci, and on cytoarchitecture, i.e., the 
organization of cell layers. A contemporary atlas was created by Talairach and Tournoux in 
1988, based on dissection of one single brain. This is a three-dimensional coordinate system 
with the origin set to the anterior commissure (AC), an easily distinguishable bundle of nerve 
fibers connecting the left and right temporal lobes. An adaptation of the Talairach space, the 
Montreal Neurological Institute (MNI) space, is the most commonly used coordinate system 
in neuroimaging to date, and used throughout in this thesis. This system is derived from MRI-
scans of a large number of healthy individuals that were scaled to match the Talairach brain. 
An average of these T1-weighted scans was used to create a template. The resulting MNI-
brain is, however, slightly larger than the Talairach brain. The MNI coordinate system also 
originates in the AC and the line between the anterior and posterior commissure is horizontal 
in a sagittal image. In the axial and coronal planes, the interhemispheric fissure is vertical. 
The coordinates are labeled X = Left (negative numbers) to Right (positive), Y = Caudal (-) 
to Rostral (+), and Z= Ventral (-) to Dorsal (+). 
 
1.2.2 Causes of volumetric change 
In the last three decades, the possibility to study brains of living individuals have been greatly 
facilitated by the development of more advanced radiological technical equipment. Magnetic 
resonance imaging (MRI) can now produce high-resolution images of soft tissues, and does 
not expose the study subjects to radiation. Neuropathological processes in brain tissue that 
previously only could be analyzed in post-mortem material can now be visualized and 
analyzed in living patients. MRI scanners are therefore frequently used in neurology and 
psychiatry clinics. Also, the scientific neuroimaging field is in a very expansive phase. Still, 
MRI does not have sufficient resolution to visualize which specific pathological processes 
that underlie the volume change. 
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Why would the structure and shape of the brain be altered in bipolar disorder?  
 A regional decrease in brain volume can cause impaired emotional regulation. This 
has mainly been documented in patiens with traumatic head injury affecting the 
frontal lobes, but also in degenerative illness such as frontotemporal dementia. 
 A regional decrease in gray matter volume has been associated with cognitive 
impairment. This is found for example in Alzheimer’s dementia. Patients with bipolar 
disorder often exhibit cognitive impairment that is correlated to the duration and 
severity of the illness (Tham et al., 1997). 
 Bipolar disorder is highly hereditary, therefore there may be neurodevelopmental 
aberrations associated with the illness. 
 
Why would the structure and shape of the brain not be altered in bipolar disorder? 
 In most illnesses with morphological brain changes, the symptoms are constant or 
gradually worsening. In bipolar disorder, the symptoms are diverse and fluctuating. 
 A large percentage of patients show no symptoms in-between episodes. Some may 
even recover completely without medication.  
 
What causes reduced brain gray matter volume? 
 Trauma, hemorrhage, infarction, infection that leads to necrosis 
 Apoptosis (Gigante et al., 2011) 
 Less dentritic branching. In schizophrenia, post mortem studies have shown reduced 
dentritic density in the prefrontal cortex (Glantz & Lewis, 2000). 
 Decreased cellular (neuronal) volume.  
 Less myelinisation (Vostrikov & Uranova, 2011) 
 Synaptic pruning 
 Less glial cells and oligodendrocytes (Ongur, Drevets, & Price, 1998; Rajkowska, 
Halaris, & Selemon, 2001) 
 
What confounds studies of brain morphology based on MRI-scans? 
Magnetic resonance imaging is not a photograph of the brain, neither an X-ray image. There 
are several factors, both physiological and technical, that can affect the MRI-signal of the 
water molecules, the conversion of signal to an image, and the pre-processing of images for 
group analyses. Thus, several factors may confound the results of MRI-scans: 
 Magnetic field inhomogeneity. The magnetic field strength is not the same in the 
whole field of view. Stronger magnets produces a more heterogenouos field. This is 
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less of a problem in analyses of small parts of the brain, but for whole-brain analyses 
this bias must be taken into account. 
 Partial volume effects. Each voxel has a volume and an intensity. The intensity of a 
voxel is the mean intensity of everything inside the volume of the voxel. This means 
that voxels on the border between tissue and water will be classified as either water or 
tissue. Hence, large voxels with a small proportions of high-intensitiy tissue can be 
mis-classified as tissue. 
 Blood flow. One study has shown that a single dose of baclofen (anti-spastic drug) 
increases blood flow to a degree that gives a false positive increase in gray matter 
volume in Voxel-Based Morphometry-analyses (VBM) (Franklin et al., 2013). 
 Brains of healthy persons are not identically shaped. Gray matter patterns and sulcal 
structures can differ more than one centimeter from one brain to another. Therefore 
can group analyses with small sample sizes be confounded by normal variation in 
brain structure. 
 Medication. A VBM study of healthy persons taking lithium for 11 days 
demonstrated a gray matter volume increase whereas an analysis of the same subjects 
with another method did not. This difference may be caused by the effect of lithium 
reducing the T1 relaxation time in gray matter (Cousins, Aribisala, Nicol Ferrier, & 
Blamire, 2013).  
 The time of day that the images are acquired. Gray matter volume decreases 
significantly from morning to afternoon, mostly in frontal and temporal regions 
(Trefler et al., 2016). This phenomenon is found regardless of whether the VBM or 
Freesurfer technique are used to analyse images. 
 The choice of method for pre-processing and analysis. The three most widely used 
softwares for volumetric analysis are Statistical Parametric Mapping (SPM), FMRIB 
Software Library (FSL), and Freesurfer. The automated segmentation differs and can 
cause different volumetric measures. The largest differences are found in cortical 
volumes whereas sub-cortical structures are more similarly assessed across these 
methods (Popescu et al., 2016).  
 
 
1.2.3 The dorsolateral prefrontal cortex 
The dorsolateral prefrontal cortex (DLPFC) is located in the frontal lobes, rostral to the 
premotor cortex. This brain region is connected to the auditory, visual, and somatosensory 
systems. It is also strongly connected to the anterior cingulate cortex (ACC). The primary 
function of the DLPFC is to process high level sensory information, for example motion and 
spatial dimensions of vision, and, through connections with the hippocampus, integrate this 
information into a context. Through the connections with the medial prefrontal cortex, this 
context is labelled with an emotion. Many illnesses that present with behavioral and cognitive 
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deficits have been associated with volumetric alterations in the DLPFC: frontotemporal 
dementia (Pan et al., 2012), Alzheimer’s dementia (Byun et al., 2015), schizophrenia (Torres 
et al., 2016), and also bipolar disorder (Lyoo et al., 2006). 
 
1.2.4 The medial prefrontal cortex 
The medial prefrontal cortex (mPFC) is involved in top-down regulation of emotional 
processes (Savitz, Price, & Drevets, 2014b). One of its main functions is to integrate input of 
context and events and, based on memory, output signals that will lead to the most favorable 
outcome (Euston, Gruber, & McNaughton, 2012). Context, in this case, also involves 
emotion based on somatosensory stimuli that has been processed in the insula. Emotional top-
town control is mostly executed from the ventral mPFC while the dorsal mPFC exerts motor 
control. One of the key areas of the mPFC is the anterior cingulate cortex. It is active in 
several processes that require inhibition of responses. The rostral part of the mPFC, the 
frontal pole, is involved in abstract thinking, meta cognition, and self-referential mentalizing 
(van Veluw & Chance, 2014). Neuroimaging and post-mortem histopathological studies have 
shown differences in mPFC between persons with bipolar disorder and healthy controls, see 
table 1.1. 
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Table 1.1. Summary of the postmortem and the neuroimaging findings in BD. 
 
 Region 
 
sgACC pgACC Supragenual ACC OFC BA 9 
Glutamatergic neuron density ↓ + − − − ↓ + 
Glutamatergic neuron number − − − − − 
Glutamatergic neuron size ↓ + − − − ↓ + 
GABAergic neuron density ↓ + ↓ ++ ↓ + ↑ + ↓ ++ 
GABAergic neuron number − ↓ + − − ↓ + 
GABAergic neuron size − − − − − 
Glial cell density − − − − ↓ ++ 
Glial cell number ↓ + − − − ↓ + 
GM volume ↓ ++ ↓ + − ↓ ++ − 
WM pathology (DTI) ++ − − + − 
Metabolic (MRS) − + − − + 
Notes: sgACC = subgenual anterior cingulate cortex, pgACC = pregenual ACC, 
OFC = orbital frontal cortex, BA 9 = Brodmann's area 9, DTI = diffusion tensor 
imaging, MRS = magnetic resonance spectroscopy. 
↑ increased, ↓ decreased, + modest evidence, ++ strong evidence, − no or minimal 
evidence. 
From: Savitz J, Price J, Drevets W. Neuropathological and neuromorphometric 
abnormalities in bipolar disorder: View from the medial prefrontal cortical network. 
Neuroscience and biobehavioral reviews. 2014; 42; 132-147. 
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1.2.5 The fronto-insular network 
The insula is the fifth and smallest lobe of the brain. It is located beneath the frontal, 
temporal, and parietal lobes. It is divided into a posterior and an anterior part which are 
divided by a sulcus that is aligned with the central sulcus of the brain surface. The anterior 
and posterior parts are cytoarchitectonically different and connect to different cortical and 
subcortical regions. The anterior insula is connected to the prefrontal, orbitofrontal, 
temporopolar, anterior cingulate areas, as well as to the somatosensory and opercular areas of 
the parietal lobe. It is also connected to the amygdala, anterior hippocampus, and the 
brainstem. The posterior insula shares connections with limbic structures and primary 
somatosensory regions. 
The anterior insula is activated when feelings are induced, such as anger, sexual arousal, trust 
and disgust (Craig, 2002). It is a key cortical area in the interoceptive network where it 
monitors the physiological status of the body. Through its connection with medial prefrontal 
areas, such as the ACC, it generates a mental image of the state of the body. Both the anterior 
insula and ACC are activated in situations that involve social errors and induce feelings such 
as guilt (Shin et al., 2000), resentment (Sanfey, Rilling, Aronson, Nystrom, & Cohen, 2003), 
embarrassment (Berthoz, Armony, Blair, & Dolan, 2002), and deception (Spence et al., 
2001). The role of this network is believed to detect social errors and adapt the responses to 
them. 
In major depression, the activity in the right anterior insula has been shown to predict 
treatment response. Interestingly, high glucose metabolism in this area has been associated 
with response to escitalopram, whereas hypometabolism have been associated with response 
to cognitive behavioral therapy (McGrath et al., 2013). 
 
1.3 MAGNETIC RESONANCE IMAGING 
In a MRI scanner, a large magnet aligns the water molecules (e.g., hydrogen 1H-protons) in 
the tissue and makes them oscillate between being aligned with the magnetic field or in the 
opposite direction. A larger magnet causes more protons to be aligned with the magnetic 
field. The protons are spinning around an axis that is close to parallel to the magnetic field. 
The slight difference in the alignment of the axis and the magnetic field makes the protons 
precess (i.e. wobble) with a certain frequency. When a radio signal (RF) with this frequency 
is turned on, the 1H-protons absorb energy and flip their spin. When the signal is turned off, 
the protons are again realigned with the magnetic field. During this process called relaxation, 
the protons release a radio frequency signal that can be picked up by a coil. The varying 
degree of water content in different tissues produces different signal strength, intensity. 
In our studies, we used T1-weighted MRI-images. T1 is the time it takes for a substance to 
become longitudinally realigned to the magnetic field following the RF pulse. A short time 
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gives a low signal, making small, free flowing molecules like water appear dark in the 
images. 
 
1.4 METHODS FOR ANLYZING BRAIN VOLUMES 
The MRI-images are made up by box-shaped units called voxels. Each voxel has a surface 
area, defined by the resolution of the image, and a height, defined by the slice thickness. The 
average intensity in the volume of the voxel gives the voxel value. 
 
1.4.1 Region of Interest-analyses 
The early studies of CT and MRI images were regions of interest (ROI)-analyses. A ROI 
analysis required that the investigator manually measured a chosen region in the brain for all 
subjects, calculated the volume, and then performed the statistical analyses. This is labor 
intensive and time-consuming work but the anatomical regions were defined with high 
accuracy. Contemporary software for image analysis, such as Freesurfer, can provide 
automated labelling of a number of pre-defined regions with an accuracy that is equal to 
manual measurements (Fischl et al., 2002). An advantage of ROI analyses is that they are not 
as easily confounded by magnetic field heterogeneity as whole-brain analyses. The downside 
of ROI-analyses is that if the ROIs are too large, volumetric differences within a part of the 
ROI may be missed. It is also impossible to tell where within the ROI the difference is 
located. If the ROIs are too small, differences outside the ROIs will be missed. Alternatively, 
one must include several ROIs which cause loss of statistical power due to correction for 
multiple comparisons. 
 
1.4.2 Voxel-Based Morphometry 
Voxel-based morphometry (VBM) is an automated method for analyzing volumes in the 
brain. It was developed by Karl Friston and John Ashburner at UCL in London, UK. The 
computer software that is used is called Statistical parametric mapping (SPM) (Ashburner & 
Friston, 2000, 2005). 
The VBM method is based on the idea that each voxel belongs to one tissue class and that the 
tissue in the voxel has a volume different from the surface x slice thickness volume. To 
enable this, pre-processing of the images is necessary. Group analyses namely require that all 
the brains have the same size and shape and that the tissue class of each voxel is defined (gray 
matter, white matter, and cerebrospinal fluid (CSF)). When the pre-processing is done, each 
voxel has a value between 1 and 0 that represents the volume of that voxel. 
The basic preprocessing steps of VBM are to: 
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 spatially normalize and warp all brain images to the same space. This is done by 
registering each image to a template by minimizing the residual sum of squared 
difference between template and image. Normalization means that some brain areas 
are expanded and others contracted. To compensate for this, and keep the original 
volume in the expanded or contracted areas, the images are modulated. Modulation 
means that the voxel value is scaled by the amount of expansion or contraction. 
 segment the images into three tissue classes (gray, white, CSF) by registering the 
spatially normalized images to tissue probability maps. 
 smooth the images. By applying a three-dimensional Gaussian kernel to the 
segmented images, the variance becomes more normally distributed and 
inhomogeneity from the spatial normalization is compensated for. 
 
Contemporary versions of SPM have integrated the normalization and segmentation steps. 
These versions also enable the use of DARTEL (A fast diffeomorphic image registration 
algorithm) to register images with higher precision (Ashburner, 2007).  
 
 
Figure 1.1. Preprocessing of images for VBM-analyses. From left to right: Raw T1 image, 
segmented gray matter image, normalized and smoothed gray matter image. 
 
1.4.3 Freesurfer 
Freesurfer is also an automated method for analyzing MRI-images on group level. Freesurfer 
has two different ways of pre-processing the images. The volume-based method for 
subcortical analyses will not be discussed here since it is not used in our studies. For analyses 
of cortical volumes, the cortical surface reconstruction method is most commonly used. Here, 
the images are first registered to a standard template. Then the white matter surface and the 
border between gray matter and CSF are outlined by calculations of differences in intensity 
between the different tissues (Figure 1.2). Hence a gray matter image is created. The image 
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contains a large number of nodes based on the position of different structures in the template. 
By interconnecting these nodes a network is created that enables the cortical surface to be 
inflated to a smooth surface with no gyri or sulci. This surface can then be anatomically 
parcellated by registering it to a probabilistic atlas (Desikan et al., 2006), thus creating 68 
anatomical regions. Then the cortical surface area of each region can be measured. To obtain 
values for cortical thickness, the distance between the gray/white matter boundary and the 
gray/CSF boundary is measured and the average thickness value for each region is calculated. 
 
Figure 1.2. Coronal (Left) and horizontal (Right) slices of the left hemisphere with 
Gray/white (yellow) and pial (red) surfaces overlaid (Fischl & Dale, 2000). 
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2 AIMS 
The overarching aim of this thesis was to advance the knowledge about the volumetric changes 
in brain gray matter in bipolar disorder and their association with specific symptoms and illness 
progression. Our specific aims were: 
- to analyze potential differences in gray matter volume, on group level, between persons with 
bipolar disorder and healthy controls. 
- to analyze the association between gray matter volume and illness progression, i.e., the 
duration of illness, the number of lifetime manic and depressive episodes, in persons with 
bipolar disorder. 
- to further investigate volume changes related to the number of manic episodes in a 7-year 
follow up to be able to separate causes from effects. 
- to investigate gray matter volume changes associated with psychosis in people with bipolar 
disorder. 
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3 MATERIAL AND METHODS 
 
3.1 THE ST. GÖRAN BIPOLAR PROJECT 
The St. Göran Bipolar Project (SBP) is a longitudinal, observational study of bipolar patients 
that started in 2005 at Affektivt Centrum, which is a tertiary out-patient unit for people with 
bipolar disorder at the Northern Stockholm Psychiatric Clinic in Sweden. All patients diagnosed 
with bipolar disorder at this unit were eligible for study inclusion. All studies in this thesis are 
based on data from the SBP. 
 
3.1.1 Assessment of diagnosis 
The patients were examined by a psychiatrist or resident in psychiatry. A semi-structured 
protocol was used to establish the diagnosis. This protocol is a Swedish version of the Affective 
disorder evaluation (ADE) protocol that was used in the STEP-BD project (Sachs et al., 2003). 
The ADE contains a social anamnesis, medical history, and the affective module of the 
Structured Clinical Interview for DSM-IV (SCID). It also includes a detailed rating of symptoms 
during manic and depressive episodes, as well as an assessment of previous psychotic 
symptoms. Comorbidity was assessed by using the M.I.N.I. International Neuropsychiatry 
Interview. Several self-rating scales, including the AUDIT and DUDIT were used to screen for 
substance misuse. All information collected from the examination, medical charts, and 
interviews with next of kin when available were presented at a diagnostic case conference with 
2-5 psychiatrists present. A best-estimate diagnostic decision was made and patients fulfilling 
criteria for bipolar disorder type I, II, not otherwise specified (NOS), and schizoaffective 
disorder bipolar type were invited to participate in the study.  
The number of participants differs across the studies in this thesis. Since study IV had been 
completed, additional patients have been included. Study I, II, and III differ due to different 
exclusion criteria for each analysis, respectively. Study V has a lower number of participants 
because all follow-up examinations had not been completed at the time of the study. 
 
3.1.2 Healthy controls 
Healthy controls were recruited by letting Statistics Sweden send letters with an invitation to 
participate to sex- and age matched, randomly selected, individuals from the same catchment 
area. Seven potential control subjects were selected for each patient and the response rate was 
14%. Responders were first screened for mental illness and other medical conditions by a 
research nurse through a telephone interview. Eligible persons were then scheduled for an 
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interview and examined by a psychiatrist using the M.I.N.I. and selected parts of the ADE to 
exclude psychiatric disorders.  
 
3.2 MAGNETIC RESONANCE IMAGING 
 
3.2.1 Image acquisition 
MRI scans were acquired in a General Electric Signa Excite 1.5T scanner at the Karolinska MR 
Research Centre from January 2006 to December 2011. Scans for the 7-year follow up were 
acquired in the same scanner. Sagittal T1 weighted, axial and coronal T2 weighted, and axial 
fluid attenuation inversion recovery (FLAIR) T2 weighted scans were acquired for examination 
by a senior radiologist to screen for clinically significant anatomical abnormalities. For the 
volumetric analyses, all subjects were examined in the same scanner and with the same protocol, 
using an eight-channel head coil. 1.8mm slices of coronal images were acquired using a three-
dimensional spoiled gradient echo recall sequence (3D-SPGR) with the following parameters: 
time to repetition=21.0ms, echo time=6ms, number of excitations=1, flip angle=30˚, acquisition 
matrix=256x256x124. Two 3D-SPGR series of images were acquired for each subject. Both 
patients and control were scanned in the afternoon at approximately the same time of day (4 
pm). 
 
3.2.2 Voxel-Based Morphometry 
In studies I, III and IV in this thesis, we used the VBM method. In study I, we used the software 
version SPM8, in study III the SPM12 version, and in study IV the SPM5 version. SPM5 differs 
in the pre-processing from the other two versions. In study IV, we also used the VBM-Toolbox 
(Gaser, 2009). In study I and III, all images were manually aligned to the anterior-posterior 
commissure line by the same investigator (C-J.E.). Images were then segmented into gray 
matter, white matter, and CSF in native space. The segmented images were rigidly aligned to the 
tissue probability map, which enables the use of DARTEL. A mean template was then created 
from the rigidly aligned gray and white matter images from all subjects. Then the deformations 
from the template to each individual image were computed and the deformations were saved as 
“Flow fields”. Using the flow fields, the gray matter images were warped to match the template 
and normalized to MNI-space. Finally, the warped and normalized images were smoothed by 
applying a three-dimensional Gaussian kernel on all voxels. In study I and III, we used a 
8x8x8mm smoothing kernel. 
In study IV, the pre-processing differed from the other studies. Here, we used two series of 3D-
SPGR images for each subject. The two series of images were realigned and resliced to yield a 
mean image for each subject. All images were then manually aligned to the anterior-posterior 
commissure line by the same investigator (C-J.E.). The mean images were then segmented into 
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gray and white matter images based on a tissue probability map. The gray matter images were 
then modulated and normalized to MNI-space. Finally the images were smoothed. In study IV, 
we used a 10x10x10mm full width at half maximum Gaussian smoothing kernel. 
Voxel-wise mass univariate analyses were performed by linear multiple regression with gray 
matter volume as the dependent variable. Continuous variables or group were used as covariates, 
and different covariates of no interest were added. Please see Study I-V for details. 
 
3.2.3 Freesurfer 
In study II and V, the MRI-images were analyzed using Freesurfer v5.1. The images were 
segmented into cortical gray matter images and the values for cortical thickness and surface area 
were obtained using the semi-automated cortical surface reconstruction method (Dale, Fischl, & 
Sereno, 1999; Fischl & Dale, 2000; Fischl, Sereno, & Dale, 1999). This method strips the skull 
from the images, defines the border between gray and white matter as well as the border 
between gray matter and CSF. The cortical gray matter images are then smoothed, transformed, 
and resampled into a standard space.  
 
3.3 ETHICS 
 
All studies were conducted in accordance with the Helsinki declaration and approved by the 
Regional Ethic Review Board in Stockholm, Sweden. All patients and controls consented orally 
and in writing to participate in the study after have been given a full disclosure of the study 
procedures. 
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4 RESULTS AND DISCUSSION 
4.1 STUDY 1  
4.1.1 Gray matter volume in bipolar patients and healthy controls 
We analyzed brain gray matter volume difference between 219 patients with bipolar disorders 
(types I, II and Not Otherwise Specified) and 102 healthy controls using a voxelwise mass-
univariate analysis (VBM) of MRI images. We corrected the analysis for age, sex, and 
scanner filter. In a post-hoc analysis, we also corrected for bipolar subtype, comorbid ADHD, 
medication, body mass index, and level of education. The main results were still statistically 
significant after controlling for these confounders (p<0.05, FWE-corrected on voxel level). 
We found that patients with bipolar disorder had smaller gray matter volume in the right 
insula (peak voxel X=44 Y=12 Z=-3 MNI-space, FWE-corrected peak voxel p=0.001, Z-
value= 4.98, cluster size 111) , left insula (peak voxel X=-39 Y=17 Z=-3, p=0.002, Z=4.81, 
98 voxels), and the right medial prefrontal cortex (peak voxel X= Y=59 Z=6, p=0.001, 
Z=5.01, 416 voxels) compared with healthy controls (Figure 4.1). 
 
Figure 4.1. Insular and frontal gray matter volume reduction in patients with bipolar 
disorder. Colored bar represents T-score. For illustrational purposes, statistical significance 
threshold was set to p<0.005 uncorrected. 
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4.1.2 Analysis of volumetric correlation 
The voxel of peak difference in the right insula was located in the anterior part, MNI-space 
coordinates X=44 Y=12 Z=-3. We extracted the volume in that voxel for each subject and 
entered it as a covariate in a whole-brain regression analysis with gray matter volume as the 
dependent variable. This was done in order to investigate if there was any other area in the 
brain which volume was linearly co-varying with the volume in the right anterior insula. We 
thus found a volumetric correlation with the left insula (not shown) and with a large part of 
the rostral and medial prefrontal cortex (Figure 4.2). 
 
Figure 4.2. Regions of the prefrontal cortex that co-varies in volume with the right anterior 
insula. 
 
The result of reduced volume in the right anterior insula corroborates a meta-analysis study 
(Selvaraj et al., 2012) . This meta-analysis also showed suggestive – but inconclusive - 
reduction of gray matter volume in the medial prefrontal cortex. Hence, our results add 
further evidence to that insular volume is reduced in bipolar disorder. We also verify that the 
medial prefrontal cortex is reduced in volume. These regions are strongly coupled to 
emotional processing. We can also demonstrate that the insula and the mPFC are 
volumetrically correlated. This suggests that it may be the same neuropathological causes to 
the volume reduction in these two regions.  
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4.2 STUDY 2 
In study 2, we compared the bipolar subtypes I and II. Using Freesurfer, we performed 
whole-brain analyses of cortical thickness, surface area, and volume in 81 patients with 
Bipolar I disorder, 59 with Bipolar II disorder, and 85 healthy controls. We found that both 
the bipolar I and II groups had smaller cortical volume in several prefrontal areas compared 
with healthy controls. The bipolar I group also showed smaller volume in temporal, occipital 
and parietal regions compared with controls. Further, the bipolar I disorder group had thinner 
rostral temporal cortex compared with the bipolar II disorder group. 
 
Figure 4.3. Smaller volume in the bipolar I disorder sample compared with controls, 
corrected for multiple comparisons (Abe et al., 2016). 
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Figure 4.4. Smaller volume in the bipolar II disorder sample compared with healthy controls, 
corrected for multiple comparisons (Abe et al., 2016). 
 
Figure 4.5. Thinner cortex in the bipolar I disorder sample compared to the bipolar II 
disorder sample, corrected for multiple comparisons (Abe et al., 2016). 
 
This study shows reduced cortical volume in the same regions as Study 1, but also in 
additional prefrontal, parietal, and occipital regions. Hence, two studies using different 
methods of image analysis show reduced volume in the medial prefrontal cortex. This study 
also corroborates the results of another large study of similar design (Rimol et al., 2012). 
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Compared with controls, the bipolar I group showed areas of low volume that was shared 
with, but larger than, the bipolar II group (Figures 3 and 4). This indicates similar underlying 
neuropathology in the two subgroups of bipolar disorder. The difference between the two 
groups may reflect the more severe symptoms in mania and depression in bipolar I disorder. 
 
4.3 STUDY 3 
In study 3, we aimed to analyze gray matter volume changes associated with a history of 
psychotic symptoms. In order to exclude disease-specific findings, we performed a case-case 
analysis of patients with bipolar disorder who had and had not experienced psychotic 
symptoms during mood episodes. Using VBM, we thus compared gray matter volume in 85 
individuals with a history of psychosis with 82 individuals without a history of psychosis. 
Level of statistical significance was set to p<0.05, family-wise error corrected on voxel level. 
In the psychosis group, we found smaller gray matter volume in the right DLPFC (peak voxel 
X=39 Y=42 Z=11 MNI-space, FWE-corrected p=0.014, T=4.98, cluster size 33 voxels), the 
left fusiform gyrus (peak voxel X=-38 Y=-33 Z=-20 p=0.010, cluster size 18 voxels, T=5.07) 
and the left inferior frontal gyrus (peak voxel X=-51 Y=18 Z=21, p=0.033, T=4.59, 9 voxels). 
The volumes in these areas were also smaller when compared with healthy controls whereas 
the no-psychosis group did not differ from healthy controls. The patient groups differed with 
respect to the distribution of bipolar disorder subtype. Bipolar I disorder was more common 
in the group with a history of psychosis, while a majority of patients in the no psychosis 
group had bipolar II disorder.  
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Figure 4.6. Regions of smaller gray matter volume in patients with bipolar disorder and a 
history of psychosis compared with bipolar patients with no history of psychosis. p<0.05 
FWE-corrected (C. J. Ekman et al., 2016). 
The regions of reduced gray matter volume are not the same as the ones Study 1 
demonstrated to be associated with bipolar disorder. This strengthens the probability that 
these regions are associated specifically with psychotic symptoms rather than with bipolar 
disorder in general. Moreover, the three regions of reduced volume have been associated with 
psychotic symptoms in other studies. The DLPFC has been associated with psychosis in 
functional MRI-studies where it shows altered signaling in prediction error tasks (Corlett et 
al., 2006; Corlett et al., 2007) . The volume of the fusiform gyrus has been shown reduced in 
schizophrenia and the reduction has also been associated with more positive 
(hallucinatory/delusional) symptoms (Song et al., 2015). Reduced volume in this region has 
also been shown in persons with auditory hallucinations who do not fulfill the criteria for 
schizophrenia (van Lutterveld et al., 2014). The inferior frontal gyrus has lower volume in 
schizophrenia patients with hallucinations than those without (van Tol et al., 2014). Hence, 
reduced gray matter volume in all three regions evidently can contribute to the development 
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of psychotic symptoms. We wanted to perform an analysis within the psychosis group, 
comparing those patients who had experienced hallucinations with those who had had 
delusions. Unfortunately too few individuals had had hallucinations without delusions so we 
did not have the statistical power do perform this analysis. The potential correlation between 
brain structure and different symptoms of psychosis is, though, a very interesting topic that 
needs to be investigated further. 
 
4.4 STUDY 4 
In study 4, we examined the relationship between gray matter volume and illness progression. 
The study included 55 patients from the St Göran Project. All patients had Bipolar I disorder 
and did not fulfill criteria for any other psychiatric illness in the M.I.N.I. screening. Using 
VBM, we performed mass-univariate linear regression analyses with gray matter volume as 
the dependent variable and either lifetime manic episodes, lifetime depressive episodes, or 
illness duration as covariates. Statistical significance was defined as p<0.05 family-wise error 
corrected on voxel level. We found a negative correlation between the lifetime number of 
manic episodes and gray matter volume in the right DLPFC (peak voxel X=47 Y=40 Z=3, p= 
0.0004 , T-score=6,79, cluster size 144 voxels) and the left DLPFC (peak voxel X=-47 Y=30 
Z=9, p=0.011, T=5.75, cluster size 38).We found no significant correlation between gray 
matter volume and the number of depression episodes or illness duration. 
 
Figure 4.7. Clusters of gray matter volume reduction that were linearly correlated to the 
lifetime number of manic episodes (C. J. Ekman, Lind, Ryden, Ingvar, & Landen, 2010). 
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Figure 4.8. Correlation between the lifetime number of manic episodes and the gray matter 
volume in the right dorsolateral prefrontal cortex. 
 
In this study, we found a linear correlation between the lifetime number of manic episodes 
and the gray matter volume of the DLPFC bilaterally. The cross-sectional design of the study 
does not make it possible to tell if the volume reductions cause a more severe illness with 
frequent manic episodes or if the reductions are caused by the manic episodes.. Interestingly, 
we found no correlation between gray matter volume and the lifetime number of depressive 
episodes. Imaging studies of unipolar depression have shown reduced GM volume in several 
cortical and subcortical regions (Arnone, McIntosh, Ebmeier, Munafo, & Anderson, 2012). 
One of the reasons we failed to demonstrate any association between GM volume and the 
number of depressive episodes may be methodological: The reported lifetime number of 
episodes has proven difficult to estimate by interviewing patients and we found much greater 
variability in the self-reports of depression than on mania.  
 
4.5 STUDY 5 
The results from Study 4 do not tell if the reduced DLPFC volume is causing higher numbers 
of manic episodes, or if it is an effect of multiple manic episodes. To further evaluate the 
cause or effect question, we analyzed MRI images from the 7-year follow up scans in the 
SBP. Out of 31 patients with bipolar disorder type 1 who at the time had been scanned at both 
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timepoints, 13 had had a manic episode during the six years whereas 18 did not. Using 
Freesurfer, we thus compared cortical thickness, volume and surface area in the DLPFC and 
inferior frontal cortex (INFRO) between the two groups at both timepoints. The regions of 
interest were automatically parcellated in Freesurfer. There was no difference in thickness or 
surface area at baseline. At follow up, the group with manic episodes demonstrated a 
significantly smaller volume in both the DLPFC and the inferior frontal cortex (Figure 4.9 
and table 4.1). 
 
Figure 4.9. Relative change in dorsolateral prefrontal cortex (DLPFC) and inferior frontal 
cortex (INFRO) volume, thickness, and surface area between the mania and no-mania groups 
at follow-up (Abe et al., 2015). 
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Table 4.1. Main results for group differences in DLPFC and inferior frontal cortex 
 
No-Mania Group Mania Group 
No-Mania versus 
Mania 
Region Measure Mean ± SD P (t) Mean ± SD P (t) P ES 
DLPFC 
Volume 
0.005 ± 
0.045 NS (0.8) 
−0.052 ± 
0.042 
<0.001* 
(−4.9) <0.001* 1.64 
Thickness 
0.039 ± 
0.042 
<0.001* 
(4.3) 
−0.015 ± 
0.048 NS (−1.6) <0.001* 1.62 
Area 
−0.041 ± 
0.033 
<0.001* 
(−5.6) 
−0.038 ± 
0.039 
0.008* 
(−3.2) NS 0.09 
INFRO 
Volume 
0.003 ± 
0.051 NS (0.4) 
−0.055 ± 
0.051 
<0.001* 
(−4.8) 0.004* 1.14 
Thickness 
0.031 ± 
0.047 0.021 (2.55) 
−0.011 ± 
0.047 NS (−1.3) 0.024 0.89 
Area 
−0.030 ± 
0.042 
0.015* 
(−2.70) 
−0.045 ± 
0.043 
<0.001* 
(−5.7) NS 0.35 
Results of main analysis on DLPFC and inferior frontal cortex (INFRO) regions of interest . 
Within-group means (±SD) of the per cent change in cortical thickness, area, and volume are 
given, along with P-values and t-statistics of one-sample t-tests (df = 12 in Mania, df = 17 in 
No-Mania). Right column: group comparison of the means (ANCOVA analysis), 
corresponding P-value, and Cohen’s d effect size. ES = effect size; NS = not significant. 
*Results significant after correction for multiple comparisons. Adjusted alpha levels were 
0.020 (No-Mania) and 0.019 (Mania) for the within-group t-tests; and 0.021 for the group 
comparison (No-Mania versus Mania). 
 
This study strongly suggests a causal relationship between manic episodes and gray matter 
reduction in the dorsolateral prefrontal cortex and the inferior frontal cortex. It also shows 
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that the volume reduction is caused by both cortical thinning and a decrease in surface area. 
Interestingly, cortical thickness is increased compared to baseline in subjects that did not have 
any manic episodes during the follow-up period. Given the fact that all of these individuals 
have had at least one manic episode prior to the baseline scanning, this cortical thickening can 
be interpreted as if the brain slowly heals during the euthymic phase.  
An effect of reduced volume could be seen even when excluding patients with multiple manic 
episodes, which means that one single manic episode cause a significant decrease in cortical 
volume. Cognitive deficits in bipolar disorder have been correlated with the number of 
hospitalizations in other studies. The DLPFC is a region involved in executive function. 
Hence, the gray matter volume reduction in DLPFC, caused by manic episodes, may be a 
neuropathological correlate to cognitive deficits.  
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5 GENERAL DISCUSSION 
 
The studies in this thesis describe volumetric alterations in the brain in persons with bipolar 
disorder. In Study 1, we found differences between bipolar disorder patients and healthy 
controls. In Study 2, we found differences between patients with bipolar disorder I and II, 
which were not associated with bipolar disorder per se. Study 3 described volumetric 
changes associated with psychotic symptoms in bipolar disorder subjects. In Study 4, we 
found a volume reduction associated with manic episodes. The finding in Study 4 was further 
investigated in Study 5 where we found that a further volume reduction occurred in patients 
that had manic episodes between baseline and follow-up but not in those that did not suffer 
from a manic episode. 
The aim of these studies was to analyze gray matter volumes in the brains of people with 
bipolar disorder to investigate if there were differences between patients and healthy controls 
and if there were differences within the patient group. We have shown that the patient group 
has smaller gray matter volume in the bilateral insula and the medial prefrontal cortex. These 
findings have also been shown in other studies which indicate that this difference is highly 
probable (Selvaraj et al., 2012). We have also shown that other cortical areas are reduced in 
volume in bipolar disorder but that these alterations are associated with symptoms and illness 
progression rather than the illness per se.  
Before drawing any conclusions, I would like to return to the diagnostic criteria for bipolar 
disorder. The individuals who have been examined in this thesis have – strictly speaking - 
only a few things in common; they have either had an episode of elevated mood for more 
than one week, or one episode of slightly elevated mood for four days and an episode of 
depression for two weeks. An important question to bear in mind when interpreting the 
results is: Do all these people have the same illness and does this illness have an underlying 
biology that is the same for all cases? 
 
5.1 METHODOLOGICAL CONSIDERATIONS? 
First, our findings underline the importance of thorough phenotyping of participants in MRI-
studies of bipolar disorder, including an assessment of the medical treatment history. A group 
of severely ill patients with a history of psychoses and many illness episodes may show 
widespread cortical volume reduction when compared with healthy controls, but not all of 
these differences are necessarily related to the bipolar disorder per se. It is therefore important 
to have a large sample size that enables control for confounding factors. But this is difficult to 
ascertain given the cost and time necessary to conduct large scale MRI studies. Alternatively, 
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the sample should be homogeneous, but narrow inclusion criteria risk reducing the 
generalizability.  
Second, the results of these studies can increase knowledge of the biological underpinnings of 
bipolar disorder. A particular facet when studying bipolar disorder is, however, that the 
illness is chronic but the patients are not chronically ill. The studies in this thesis were 
performed on euthymic patients. This means that none of the findings are associated with the 
symptoms of acute mania or depression. It is more likely that the volume reductions found in 
study I, II, and III represent a vulnerability to develop mania, hypomania, depression, or 
psychosis. We know that bipolar disorder is not a single-gene disease and research has not 
presented any single environmental factor that causes the illness. Therefore it is likely that 
bipolar disorder have multifactorial causes. The findings from Study III suggest that 
psychotic symptoms during mood episodes in bipolar patients are associated with a smaller 
cortical volume in the DLPFC and fusiform gyrus. Yet, these persons are not chronically 
psychotic. The psychosis requires some other factor, in this case mania or depression, to 
develop. Analogous, persons with smaller volume in the insula and mPFC are more likely to 
develop mania, or depression but the acute symptoms require some other triggering factor. 
 
5.2 CAN THE RESULTS FROM THESE STUDIES GUIDE DIAGNOSTIC 
DECISIONS?  
A relevant clinical question is whether the findings in this thesis can guide diagnostic 
assessments. Thus, can a brain MRI-scan inform the clinician about whether a patient has 
bipolar disorder or some other psychiatric disorder? Our studies were, however, not designed 
to answer that question. All cases were diagnosed with bipolar disorder prior to the brain 
scan, and all controls were known not to suffer from a psychiatric disorder prior to inclusion. 
Hence, we cannot apply the results we get from analyses between bipolar disorder and 
healthy controls to inform clinical diagnostic decisions. Moreover, the methodology we have 
used in these studies did not have the specificity to distinguish a person with bipolar disorder 
from a healthy person on an individual level. The effect sizes of the volume reductions found 
in the bipolar vs. controls whole-brain study represents a Cohen’s d of ~0.6 which means that 
approximately ¾ of the subjects will overlap in insular volume. More importantly, the clinical 
challenge is not to differentiate bipolar disorder from a healthy person: When patients present 
to psychiatric care, we know from the outset that the person have some psychiatric illness. It 
can be more challenging to distinguish a first manic episode with psychosis from a first-
episode schizophrenia, and even more challenging to separate bipolar II disorder from 
borderline personality disorder, ADHD, or recurrent depression. We therefore need studies 
directly comparing cases with these different diagnoses. If such studies would reveal for 
example that the insular or medial prefrontal volume, or a combination of those, is a 
distinguishing trait for bipolar disorder, imaging techniques can be optimized for these 
regions.  
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5.3 SHOULD WE BELIEVE THE RESULTS? 
When performing whole-brain analyzes of gray matter volume, differences between groups 
can appear in unexpected regions of the brain. These differences can be true or caused by the 
various confounders listed in the introduction of this thesis. Analyses of brain morphology 
that are not designed to verify any other hypothesis than “There is probably some difference” 
must therefore be interpreted with precaution. Studies 1 and 2 showed structural differences 
between people with bipolar disorder and healthy controls in the insular and medial prefrontal 
cortices. Could a malfunction of these regions play a role in mania or depression? The insula 
monitors the state of the body by receiving input from various parts of the body regarding, 
e.g., heart rate, body temperature, and bowel movement. It summarizes these different factors 
into an emotional state. Through its connections with the medial prefrontal cortex, it creates a 
conscious feeling. The emotional state always precedes the feeling. The mPFC integrates the 
emotional state with context and past experience to create the feeling. For example, a 
marathon runner who has crossed the finishing line can feel happiness despite severe muscle 
pain, fast heartrate, high body temperature, and dehydration, i.e. visceral stimuli that normally 
are associated with discomfort or illness. But a malfunctioning mPFC might not be able to 
put the emotional state into context. In depression, the core symptom is that happiness cannot 
be felt in a context that past experience associates with this particular feeling. This can be due 
to a malfunction in the mPFC or that the emotional state is so severe that it cannot be 
modified by mPFC top-down regulation. In mania, the inhibitory regulation of behavior, 
based on past experience, is often insufficient, which leads to risk-taking and excessive 
involvement in pleasurable activities. An interesting discovery in this context is the 
involvement of the insula in the rare cases of ecstatic epileptic seizures (Gschwind & Picard, 
2016). The authors describe cases of epilepsy that have ecstatic auras where the patient 
experiences enhanced physical well-being, heightened self-awareness and/or perception of 
the external world, feelings of overload, but in some cases also anxiety. These seizures can be 
elicited by electrodes planted in the anterior insula. The symptoms closely resembles the 
emotional state of mania apart from that their duration is much shorter. The biological causes 
of a true manic episode are unknown. The diversity in clinical presentation of mania might be 
explained by that an elevated emotional state, created in the anterior insula, is regulated 
differently by the mPFC, creating feelings of euphoria or irritability in different individuals 
and at different timepoints.  
Based on what we know about the functions of insula and the mPFC, it is highly probable 
that these regions are involved in the development of the symptoms of both mania and 
depression. 
The results of study 3 have been briefly discussed in the previous section. All three regions of 
GMV reduction have been associated with psychosis in other studies. Interestingly, the 
results lend support for the two-factor theory of psychotic symptoms (Coltheart, 2010). This 
theory implies that, for a delusion or hallucination to develop, a misinterpreted stimulus in 
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one brain region is not rejected as false in another region. Reduced volumes in the fusiform 
gyrus and the inferior frontal gyrus have been associated with hallucinations and may be the 
first factor of the model. The second factor would then be the rostral DLPFC, which is 
associated with reality testing.  
The results from study 4, showing that reduced GMV in the bilateral DLPFC correlated to the 
lifetime number of manic episodes, are also in line with other studies of bipolar disorder. 
Smaller volume in the DLPFC, compared with healthy controls, has been associated with 
bipolar disorder, for example study 2. The most valid support of this result is our own results 
from study 5. The DLPFC is involved in executive functions but although some studies have 
shown a correlation between GMV in this region and cognitive performance (Hartberg et al., 
2011) others have not (Alonso-Lana et al., 2016). DLPFC volume reduction has been found 
in patients with depression that do not reach complete remission (Li et al., 2010). Hence, 
GMV reduction in DLPFC is found in bipolar disorder. This reduction is, at least in part, 
progressive, but the correlation between this reduction and clinical presentation has yet to be 
established. 
In summary, despite the exploratory designs of studies 1-4 the results of volumetric 
alterations have a high probability of being true. This is mainly due to the correction for 
confounders in the analyses, the stringent threshold for statistical significance, and last but 
not least the support gained from similar findings in other studies. 
  
 
5.4 IS BIPOLAR DISORDER A PROGRESSIVE NEURODEGENERATIVE 
ILLNESS? 
Little is known about premorbid gray matter volume alterations in patients with bipolar 
disorder. There are a few MRI studies performed on bipolar children and adolescents. 
Moreover, when interpreting such studies one must remember that these patients represent a 
subgroup of bipolar patients with a poorer outcome(Suominen et al., 2007) and the results 
cannot readily be generalized to the whole bipolar disorder group. Retrospectively, many 
adult patients have had symptoms of the illness in their teenage years but only the most 
severe cases get a diagnosis of bipolar disorder in that early age. A recent study of 
adolescents with bipolar disorder has shown that the gray matter volume in the anterior insula 
and DLPFC reduces over two years’ time in the late teenage years (Najt et al., 2016). Our 
Study 5 focused only on the DLPFC but found no volume reduction in those patients who did 
not have any manic episodes during the seven-year follow-up. Studies of cognitive function 
have not established faster decline with ageing in bipolar patients than controls, but a 
negative association with the number of mood episodes, hospitalizations, and illness duration 
(Cardoso, Bauer, Meyer, Kapczinski, & Soares, 2015). Taken together, these findings suggest 
that bipolar disorder may be associated with gray matter volume reduction at the time of 
onset but further reductions depend on the course of the illness. This means that there can be 
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different causes to the volume reductions found at onset and those developing during the 
course of illness. Chronic stress causing high cortisol levels and glutamate-induced 
excitotoxicity has been suggested as a mechanism for progressive volumetric changes (Olney, 
Newcomer, & Farber, 1999) (Czeh et al., 2007). Classical biomarkers of neurodegeneration 
are not found in bipolar disorder (β-amyloid, gliosis, Lewy body inclusions) (Jakobsson et al., 
2013). A recent review of the literature (Savitz, Price, & Drevets, 2014a) defines bipolar 
disorder as a “progressive neurodevelopmental disorder”. That means that the causes for the 
onset of the illness are neurodevelopmental but that the manic and depressive episodes cause 
glial and neuronal degeneration. This definition of the illness fits well with the results in this 
thesis since we find volume differences in disparate areas when comparing patients and 
healthy controls from when analyzing differences correlated to illness progression in the 
patient group. 
 
5.5 WHAT IS REDUCED? 
The differences in gray matter volume between healthy controls and patients with bipolar 
disorder are located in the insula and medial prefrontal cortices. The fronto-insular region has 
a relatively high density of von Economo neurons (VENs). Studies of behavioral variant 
fronto-temporal dementia, displaying mania-like symptoms, have shown volume reduction 
and degeneration of these von Economo neurons in the fronto-insular region (Seeley et al., 
2007; Seeley, Crawford, Zhou, Miller, & Greicius, 2009). Also, a study of persons with 
alcoholism showed a 10% smaller anterior insular volume and 60% less von Economo 
neurons post mortem (Senatorov et al., 2015). Interestingly, there are more von Economo 
neurons in the right hemisphere. The right/left ratio is 1.24 in the anterior insula and 1.9 in the 
ACC in the adult brain (Allman et al., 2010). It was on the right side that we in Study 1, as 
well as a meta-analysis (Selvaraj et al., 2012), found the largest difference in volume.  
The von Economo neurons are much larger than pyramidal cells and their apical and basal 
dendrites are symmetrical. The symmetry suggests that the neuron compares input from both 
ends (Watson, Jones, & Allman, 2006). The dendritic branching is narrow and the VEN is 
believed to rapidly relay output from one very specific area to another. The VENs of the 
anterior insula and ACC are activated by social errors. During a manic state, the reactions to 
one’s own social errors are often markedly reduced but the reactivity and awareness of 
others’ is increased. There are no studies of insular VEN density in bipolar disorder, but one 
study has shown normal VEN density in the ACC (Brune et al., 2010). If the VEN density is 
not reduced in BD there may still be other implications that the VENs are affecting gray 
matter volume. Single nucleotide polymorphisms of the DISC1 (disrupted in schizophrenia 1) 
gene have been associated with bipolar disorder. 90-94% of VENs in humans expresses the 
protein encoded by DISC1 compared to 34-37% of other layer 5 pyramidal neurons (Allman 
et al., 2010). The DISC1 protein regulates the dendritic branching of neurons (Duan et al., 
2007) and one single nucleotide polymorphism (SNP) of the DISC1gene is associated with 
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reduced ACC volume (Hashimoto et al., 2006). The volume reduction can be caused by 
altered dendritic branching rather than reduced neuronal density. 
Post-mortem studies have shown reduced glial density in the medial prefrontal cortex (Ongur 
et al., 1998) as well as in the DLPFC (Rajkowska et al., 2001). Both these areas have been 
shown reduced in bipolar disorder, although our study 1 found less volume only in mPFC. 
The role of glia cells in bipolar disorder is an emerging research field. Most studies have 
focused on oligodendrocytes. These cells represent 35% of all glia cells in the brain and one 
of their functions is to provide myelination of neurons. In the healthy brain, myelination 
continues until the age 40 but there are data suggesting reduced age-related cortical 
myelination in bipolar disorder (Vostrikov & Uranova, 2011). Oligodendrocytes express 
AMPA glutamate receptors and are therefore sensitive to damage caused by excess 
glutamate-mediated activation (McDonald, Althomsons, Hyrc, Choi, & Goldberg, 1998). In 
study 5, we showed that patients that had manic episodes decreased in cortical volume in the 
DLPFC. This could be due to stress-induced oligodendrocytal damage. Also, the levels of 
cortisol and other stress hormones are increased both during depression and mania. Chronic 
administration of cortisol to rats has shown to induce reorganization of the dendrites of 
pyramidal neurons in the DLPFC (Radley et al., 2004). Patients with no episode showed no 
volume change but an increase in cortical thickness. Atypical antipsychotic drugs are thought 
to promote intracortical myelination (Bartzokis et al., 2012). Many studies measuring 
biomarkers in CSF have found markers of microglial activation associated with all stages of 
bipolar disorder. A link between dysfunctional emotional regulation and low glial cell count 
has though not been established. 
 
5.6 FREESURFER OR VBM, WHICH ONE IS THE PREFERABLE METHOD? 
In this thesis, we used two different softwares for analyzing brain structure, Statistical 
Parametric Mapping and Freesurfer. Both methods uses differences in T1 signal intensity to 
segment images into different tissue classes (GM, WM, CSF), but the method of 
segmentation differs. A few multimodal studies have found differences in cortical volume 
measures between Freesurfer and the SPM8 version (Popescu et al., 2016; Rajagopalan & 
Pioro, 2015). The differences are though not the same across studies. In one study, the 
Freesurfer method showed more positive findings than SPM and vice versa in the other.  
When interpreting studies of brain volumetry, no matter what software, it is important to 
recognize what method of correction for multiple comparisons that has been applied and what 
level of statistical significance that has been used.  
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5.7 HOW SHOULD FUTURE STUDIES OF BRAIN STRUCTURE BE 
CONDUCTED?  
MRI-studies of humans are time consuming and expensive. As we have seen in the studies in 
this thesis there are a lot of factors that confound the results of volumetric analyses of the 
brain. Some of them are strictly methodological and can quite feasibly be dealt with. For 
example using the same scanner and scanning parameters, scanning subjects at the same time 
of day. Medications such as lithium alter the T1-signal but tampering with the medication 
conveys a substantial risk for the patient and should be avoided. Selection of subjects is of 
course dependent on the hypothesis. When it comes to studies of bipolar disorder it is often 
hard to choose exclusion criteria. If one narrows the criteria only to include bipolar I patients 
with no comorbidities one is not guaranteed to find results that are generalizable to the whole 
bipolar population. Since 67% of bipolar I patients have experienced some other psychiatric 
illness these “pure” cases should rather be considered as a subgroup. Analyses of large 
cohorts of patients that are phenotyped in detail can describe volumetric changes associated 
with each comorbid condition. 
Multi-center studies are effective in collecting a large number of patients in a shorter time and 
the costs are spread over many institutions. To this day, only smaller prospective multi-center 
studies have been conducted. Data in the present neuroimaging consortia is collected from 
studies already performed at the collaborating centers. This means that differences in MRI-
scanner settings will confound the results. Even though the total number of subjects is large 
in these studies each center must provide a fairly large number of subjects and healthy 
controls to enable analyzes of group x center interactions. As we have seen, the effect sizes in 
whole brain analyzes of bipolar disorder are small, partly because of the correction for 
multiple comparisons. Therefore, present studies have mostly focused on subcortical 
structures that can be automatically segmented. 
No matter how well conducted the studies are, the main question is if structural imaging 
studies can solve the mystery that is Bipolar Disorder. We do not know the answer to that 
question yet. To come closer to an answer, studies of brain structure in the different polarities 
of the illness must be performed. Almost all studies have included euthymic patients. If we 
were to find differences in brain structure in the same individual that varies during mania, 
euthymia, and depression, then the importance of structural studies would increase. Also, we 
do not yet know what image resolution the next generations of imaging tools will provide. 
Where we stand today, structural imaging cannot find the answer to what causes bipolar 
disorder, but the results presented in this thesis can guide studies of other modalities, such as 
histopathological analyses. Since we have robust findings of decreased cortical volume in a 
few regions, future studies should focus on what type of cells that are reduced in volume or 
number in these regions. 
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